Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7354 p753
18 June 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Treatment beneficial in pregnancy-related diabetes

Treating women who develop mild diabetes during pregnancy may improve their quality of life and reduce complications for their offspring, according to a new study.

Researchers explain that there has been uncertainty over whether screening and treatment of gestational diabetes to reduce maternal glucose levels reduces the risks associated with the condition (such as fetal death, shoulder dystocia, bone fracture and nerve palsy). There has also been concern that treatment may increase the risk of caesarean birth and induced labour as well as increase the risk of maternal anxiety and depression.

They therefore assigned 1,000 women (in Australia and the UK) who had gestational diabetes to receive either dietary advice, blood glucose monitoring and insulin therapy, as needed, or routine care.

Treatment reduced the rate of serious perinatal complications (from 4 per cent to 1 per cent). This benefit was not at the expense of an increased caesarean birth rate. However, treatment did appear to increase the rate of labour induction as well as the rate of admission to a neonatal care unit for the child.

The study is published in The New England Journal of Medicine (2005;352:2477).

Back to Top


©The Pharmaceutical Journal